Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation
- PMID: 21610240
- PMCID: PMC3105776
- DOI: 10.1001/jama.2011.659
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation
Abstract
Context: The risks associated with new-onset atrial fibrillation (AF) among middle-aged women and populations with a low comorbidity burden are poorly defined.
Objectives: To examine the association between incident AF and mortality in initially healthy women and to evaluate the influence of associated cardiovascular comorbidities on risk.
Design, setting, and participants: Between 1993 and March 16, 2010, 34,722 women participating in the Women's Health Study underwent prospective follow-up. Participants were 95% white, older than 45 years (median, 53 [interquartile range {IQR}, 49-59] years), and free of AF and cardiovascular disease at baseline. Cox proportional hazards models with time-varying covariates were used to determine the risk of events among women with incident AF. Secondary analyses were performed among women with paroxysmal AF.
Main outcome measures: Primary outcomes included all-cause, cardiovascular, and noncardiovascular mortality. Secondary outcomes included stroke, congestive heart failure, and myocardial infarction.
Results: During a median follow-up of 15.4 (IQR, 14.7-15.8) years, 1011 women developed AF. Incidence rates per 1000 person-years among women with and without AF were 10.8 (95% confidence interval [CI], 8.1-13.5) and 3.1 (95% CI, 2.9-3.2) for all-cause mortality, 4.3 (95% CI, 2.6-6.0) and 0.57 (95% CI, 0.5-0.6) for cardiovascular mortality, and 6.5 (95% CI, 4.4-8.6) and 2.5 (95% CI, 2.4-2.6) for noncardiovascular mortality, respectively. In multivariable models, hazard ratios (HRs) of new-onset AF for all-cause, cardiovascular, and noncardiovascular mortality were 2.14 (95% CI, 1.64-2.77), 4.18 (95% CI, 2.69-6.51), and 1.66 (95% CI, 1.19-2.30), respectively. Adjustment for nonfatal cardiovascular events potentially on the causal pathway to death attenuated these risks, but incident AF remained associated with all mortality components (all-cause: HR, 1.70 [95% CI, 1.30-2.22]; cardiovascular: HR, 2.57 [95% CI, 1.63-4.07]; and noncardiovascular: HR, 1.42 [95% CI, 1.02-1.98]). Among women with paroxysmal AF (n = 656), the increase in mortality risk was limited to cardiovascular causes (HR, 2.94; 95% CI, 1.55-5.59).
Conclusion: Among a group of healthy women, new-onset AF was independently associated with all-cause, cardiovascular, and noncardiovascular mortality, with some of the risk potentially explained by nonfatal cardiovascular events.
Comment in
-
Mortality risk among middle-aged women with first atrial fibrillation.JAMA. 2011 May 25;305(20):2116-7. doi: 10.1001/jama.2011.699. JAMA. 2011. PMID: 21610247 No abstract available.
-
Atrial fibrillation: new-onset AF in women--an independent risk factor or a 'canary in a coal mine'?Nat Rev Cardiol. 2011 Jun 7;8(7):361. doi: 10.1038/nrcardio.2011.84. Nat Rev Cardiol. 2011. PMID: 21647182 No abstract available.
-
ACP Journal Club. New-onset atrial fibrillation was associated with increased risk for mortality in initially healthy, middle-aged women.Ann Intern Med. 2011 Sep 20;155(6):JC3-12, JC3-13. doi: 10.7326/0003-4819-155-6-201109200-02012. Ann Intern Med. 2011. PMID: 21930849 No abstract available.
-
Mortality in women with new-onset atrial fibrillation.JAMA. 2011 Sep 21;306(11):1200-1; author reply 1201. doi: 10.1001/jama.2011.1322. JAMA. 2011. PMID: 21934050 No abstract available.
References
-
- Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–2375. - PubMed
-
- Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119–125. - PubMed
-
- Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131(4):790–795. - PubMed
-
- Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28(2):316–321. - PubMed
-
- Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364. - PubMed